Cargando…
Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
It is now reported that coronavirus disease 2019 ICU patients are at increased risk of thrombosis. Expert opinion and scientific societies recommend a higher dose of low-molecular-weight heparin, but definitive data is lacking. We report our adapted thromboprophylaxis practice of low-molecular-weigh...
Autores principales: | Piagnerelli, Michaël, Cauchie, Philippe, Vancutsem, Maxime, Thooft, Aurélie, Zouaoui Boudjeltia, Karim, Biston, Patrick, Wautrecht, Jean-Claude |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392617/ https://www.ncbi.nlm.nih.gov/pubmed/32766568 http://dx.doi.org/10.1097/CCE.0000000000000177 |
Ejemplares similares
-
Serum Metabolomic Profiles in Critically Ill Patients with Shock on Admission to the Intensive Care Unit
por: Thooft, Aurélie, et al.
Publicado: (2023) -
Effects of Preconditioning on RBC Deformability in Critically Ill Patients
por: Moreau, Anthony, et al.
Publicado: (2022) -
Plasma fibrinolysis is related to the degree of organ dysfunction but not to the concentration of von Willebrand Factor in critically ill patients
por: Boudjeltia, Karim Zouaoui, et al.
Publicado: (2009) -
Interpretation of C-Reactive Protein Concentrations in Critically Ill Patients
por: Lelubre, Christophe, et al.
Publicado: (2013) -
What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
por: Cauchie, Philippe, et al.
Publicado: (2021)